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ABSTRACT 
Cleistanthus collinus is a poisonous plant seen in Tamil Nadu. The leaves of Cleistanthus 
collinus is commonly used for suicide. Mortality rate is about 28% and the death occurs 
usually around three to seven days after ingestion of poison. The toxic principles 
extracted from Cleistanthus collinus are Cleistanthin A and Cleistanthin C of which 
Cleistanthin C is mainly present in boiled extract. The mechanism by which this toxin 
acts is unknown. Hypotension is one of the clinical features of the poisoning. Earlier it 
was thought to be of cardiac origin. But later hypotension was suggested to be due to 
peripheral vasodilatation as systemic vascular resistance was very low in these patients. 
Catecholamines are the main treatment of choice for shock that may occur due to 
hypotension in the poisoning. But catecholamines seldom improve the condition of these 
patients and death is often inevitable.  
Aim  
     To assess the effect of Cleistanthin C on vascular resistance.                                                                                                               
Objectives 
   1. To perfuse the hind limb preparation of rat with a steady flow rate through the 
descending aorta and record aortic pressure with a pressure transducer. 
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   2. Derive resistance from the pressure wave form mathematically using algorithms 
developed in the department 
   3. Use the above preparation to study the effect of Cleistanthin C on vascular 
resistance. 
Methods 
Cleistanthin C was isolated from Cleistanthus collinus leaves by Thin Layer 
Chromatography (TLC). Cleistanthin C was confirmed using High Performance Liquid 
Chromatography (HPLC). 
Wistar rat isolated hind limb preparation was used in our study.  It was perfused with 
physiological salt solution and the blood pressure was recorded using a pressure 
transducer connected to CMC data acquisition system (CMC Daq). The rate of perfusion 
was fixed by using peristaltic pump at 4ml/min. For the study, rats were divided into 
three groups. The preparation was perfused with Cleistanthin C (test) or ethanol (control) 
for 15 to 20 minutes. After this either phenylephrine (group 1), or adrenaline (group 2) or 
noradrenaline (group 3) was added. The change in pressure was recorded using pressure 
transducer.  After that resistance was calculated using software developed in our 
department using curve fitting method. 
Results 
Cleistanthin C at low dose did not produce any change in the vascular resistance, while at 
high dose increased the vascular resistance.  In the presence of Cleistanthin C 
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catecholamines like phenylephrine, adrenaline and noradrenaline increased the vascular 
resistance as in control groups. There was no significant difference in the experiment and 
control groups. 
Conclusion 
Cleistanthin C, one of the toxic principles of Cleistanthus collinus, increases vascular 
resistance at high dose.  In the presence of Cleistanthin C, catecholamines increased the 
vascular resistance similar to control group showing that Cleistanthin C would not affect 
the action of catecholamines. 
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INTRODUCTION 
 
Toxicology is the study of all the symptoms due to ingestion of poisonous substance, the 
mechanism of action of the toxin and the treatment for poisoning. India was ranked first 
in suicide rate in 2012 (1). Poisoning is one of the commonest modes of suicide. 
Cleistanthus collinus commonly called as Oduvanthalai is the commonest plant poisoning 
seen in Tamil Nadu (2). All the parts of Cleistanthus collinus are poisonous. People use 
the leaves in different forms like aqueous extract or decoction for suicide. The poisonous 
components isolated from Cleistanthus collinus leaves include Cleistanthin A and 
Cleistanthin C (3). Cleistanthin C is mainly seen in boiled extract which is the most 
poisonous form. The research works in our department are focussed on finding out the 
mechanism of action of Cleistanthus collinus poisoning.  
Mechanism of action of this poisoning is not known yet. Proposed mechanisms of action 
are cardio respiratory dysfunction, distal renal tubular acidosis, electrolyte imbalance, 
hypotension, neuromuscular weakness, inhibition of Na
+
-K
+ 
pump, glutathione depletion, 
K
+ 
channel blockade etc (4) (5). 
Mortality rate is 28% and death occurs 3-7 days after poison ingestion. Clinical features 
of Cleistanthus collinus poisoning include hypotension, breathlessness, tachycardia etc. 
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The hypotension was found not to be of cardiogenic origin. This hypotension can lead to 
shock and death of patients (6).  
Vascular tone plays an important role in blood pressure regulation and distribution of 
blood to various tissues and organs. Vascular tone depends on stimuli from 
neurotransmitters, circulating hormones and endothelium derived factors. Ion channels 
also have a role in maintaining vascular tone. Smooth muscle of blood vessel contains 
voltage gated calcium channels, chloride channels, potassium channels and store and 
stretch operated channels (7). 
A recent MD (Medicine) thesis from the Department of Medicine, Christian Medical 
College, Vellore has shown severe intractable hypotension presenting on the 3
rd
 - 4
th
 day 
with normal cardiac inotropy and chronotropy as demonstrated by daily 
echocardiography, holter and ECG monitoring in Oduvanthalai poisoning patients 
(unpublished data). At the presentation of hypotension the patients had normal renal 
function. The intractable hypotension in the poisoning was suggested to be due to 
peripheral vasodilation as systemic vascular resistance was low for these patients. 
 Vascular smooth muscles lining the blood vessel relax excessively to produce 
vasodilation. Smooth muscles contain two types of adrenoreceptors, α and β. α receptor 
activation produces vasoconstriction and β receptor produces vasodilation (8).  
Vascular smooth muscle contractions are driven by an agonist induced cytosolic Ca
2+
 
oscillator that generates a periodic release of Ca
2+ 
from the endoplasmic reticulum that 
appears as propagating Ca
2+
 wave (9). The oscillator is induced by ligands such as 
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epinephrine, norepinephrine, angiotensin II, thrombaxane, vasopressin and endothelin-1, 
which act through inositol 1,4,5-trisphosphate (InsP3) mediated SR(sarcoplasmic 
reticulum) calcium release (10). 
The oscillator is dependent on Ca
2+
 entry for charging up the stores for every oscillatory 
cycle. This Ca
2+ 
entry is through Na
+
-Ca
2+
 Exchanger (NCX) in reverse mode (11), 
purinergic receptor P2X which is responsible for junctional Calcium transients (12) and L 
type Calcium channels (13). It can occur also through some subtypes of Transient 
Receptor Potential (TRP) ion channels like TRPC3 and TRPC7 (14) (15). 
The initial release of Ca
2+
 is then amplified by Ca
2+
 induced Ca
2+
 release (CICR) from the 
stores by Ryanodine receptor (RyR) or Inositol triphosphate receptor(IP3R) (16) (17). 
The global increase in Ca
2+
 will activate contraction. Another effect of increased Ca
2+
 is 
to stimulate Ca
2+
 sensitive Cl
-
 channels. This causes membrane depolarisation and 
increases opening of L type Calcium channels, leading to further membrane 
depolarisation.  
The relaxation phase depends on Plasma Membrane Ca
2+
 ATPase (PMCA), 
Sarco/Endoplasmic Reticulum Ca
2+
 ATPase (SERCA), and NCX in forward mode which 
decreases the cytosolic Ca
2+ 
(18) (19). 
One effect of increased global Ca
2+
 is to stimulate Ca
2+
 sensitive K channels (BK and 
SK) which causes membrane hyperpolarisation (20). 
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Ca
2+
 oscillation also depend on ATP. ATP is released from vascular smooth muscle cells 
through membrane transporters, ABC transporters and channels including connexin 
hemichannel, pannexin channel. ATP acts via purinergic receptors P2X and P2Y. ATP 
will act on P2X receptor to produce vasoconstriction and P2Y receptor to produce 
vasodilatation (21). 
Nitric oxide is a vasodilator which act via protein kinase G activation to cause 
dephosphorylation of myosin light chain (22). In the presence of excess NO 
catecholamines can produce vasodilatation (23).  
Any change in this normal calcium oscillation, or release of nitric oxide, may be a cause 
for vasodilatation that occurs in Cleistanthus collinus poisoning. 
Experiments done in isolated goat artery in our laboratory showed that catecholamines in 
the presence of Cleistanthin C can produce vasodilatation (data to be published). 
Similarly in whole animal experiments in Wistar rats, Cleistanthin C induced hypotension 
and catecholamines following that could not increase the pressure (2017 M.D. 
Physiology thesis by Dr Sajal C Singh).  
Vascular tone of small arteries as well as arterioles determines the resistance of the 
circulation. Vascular resistance is due to friction of blood while flowing through a vessel. 
It is the impedance to the blood flow. It cannot be measured by direct means. It is 
calculated from blood flow and pressure difference. 
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R=∆P / Flow   
Resistance is calculated as, R = 8ηl/πr4 by Poiseuille's law. So the resistance is inversely 
proportional to the fourth power of radius. Even a small decrease in radius will cause 
very large increase in resistance. 
Blood that is pumped from heart will pass through aorta, arteries, arterioles, capillaries, 
venules and veins that are arranged in series and therefore the resistance of total systemic 
circulation is the sum of the resistance of each vessel. 
R total = R1+R2+R3... (24).  
The aim of our study was to assess the effect of Cleistanthin C on vascular resistance. 
Since in patients with hypotension and shock catecholamines are the major treatment 
option, we also wanted to see the effects of catecholamines like phenylephrine, 
adrenaline and noradrenaline after giving Cleistanthin C.  
Wistar rats were used for the study. The model used was hind limb preparation. The rat 
hind limb preparation is better for assessing effects of Cleistanthin C on vascular 
resistance. The advantage of this preparation is that cardiac function and neural reflexes 
are eliminated and flow can be regulated. In our study, an anaesthetized rat was cut 
through the abdomen, and abdominal aorta was cannulated. A pressure transducer and 
peristaltic pump were connected to the cannula through a three-way tap, for pressure 
recording and perfusion respectively.  The aorta was perfused with extracellular fluid 
with either Cleistanthin C (test) or ethanol (control) for 20 to 30 minutes. Then it was 
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perfused with extracellular fluid containing a) phenylephrine 10μM OR b) adrenaline 
15µM OR c) noradrenaline 12µM.  Blood pressure was recorded continuously using 
CMC Daq connected to laptop. Vascular resistance was calculated using software 
developed in our department based on the Windkessel model. Windkessel equation is  
𝑸 =  
𝑷(𝒕)
𝑹
+ 𝑪
𝒅𝑷(𝒕)
𝒅𝒕
 
 Using an algorithm, the resistance was calculated using a curve fitting method were 
pressure wave was fitted to the flow wave. Resistance changes due to catecholamines 
were assessed by comparing average resistance over a period of 5 minutes before and 
after the intervention.  
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AIMS AND OBJECTIVES 
AIM 
 
To assess the effect of Cleistanthin C on vascular resistance. 
OBJECTIVES 
 
 1. To perfuse the hind limb preparation of rat with a steady flow rate through the 
descending aorta and record aortic pressure with a pressure transducer. 
 2. Derive resistance from the pressure wave form mathematically using software 
developed in the department. 
 3. Use the above preparation to study the effect of Cleistanthin C on vascular resistance. 
 4. To study the effect of vasoconstrictors like adrenaline, phenylephrine, and nor 
adrenaline on vascular resistance in the presence of Cleistanthin C.  
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LITERATURE REVIEW 
Cleistanthus collinus 
Toxicology is “the science of poisons” that studies the various adverse effects of toxins 
on living organisms. Toxicology includes the symptoms due to ingestion of the toxic 
substance, the mechanism of action of toxin, toxin detection in the body and its treatment 
(25). 
India recorded the highest number of suicides and was designated as “Suicide Capital of 
South-East Asia” in 2012. National Crime Records Bureau (NCRB) reports that 34.4% of 
suicides are performed by individuals between 15 and 29 years, and 33.8% between 30 
and 44 years. WHO reports a suicide rate of 8, 00,000 every year. Of this 17 % are 
Indians. Reports show that Tamil Nadu, West Bengal and Andhra Pradesh have reported 
higher number of suicide deaths (2). 
According to a study done by Bose et al the common modes of suicide were poisoning 
and hanging. Poisoning was either by pesticides (61%) or by poisonous plant (19%). The 
common plant poisons include Oleander and Cleistanthus collinus (26). 
Cleistanthus collinus belongs to the family Euphorbiaceae. It is commonly called as 
Oduvanthalai in Tamil. In Malayalam it is known as Nilapala and in Hindi it is known as 
Garari. Although this poisonous shrub is seen commonly in different part of India this is 
used for poisoning only in Tamil Nadu (27). All parts of the plant like leaves, fruits and 
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bark are poisonous. The leaves are used as abortifacient in some parts of our country. It 
has also been used as cattle and fish poison. Usually people take leaves in different forms 
like decoction (boiled extract), aqueous extract or grounded leaves for poisoning. Boiled 
extract is the most poisonous of the three (28).  
 
 
 
Many toxic and non toxic components have been identified from Cleistanthus collinus. 
Oduvin was the first one to be identified which was a slow poison. Irudayasamy and 
Natarajan found that it contains Principle A and Principle B (29). Later Cleistanthin and 
collinusin which are lignan lactones; and diphylline and ellagic acid were isolated from 
the leaves of Cleistanthus collinus (6). Collinusin and cleistanone are present in the aerial 
parts of Oduvanthalai (6). Cleistanthin B which has a diphylline – O- lycoside structure 
Figure 1- Cleistanthus collinus leaves. 
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was identified by Subba Rao. He named the first identified Cleistanthin as Cleistanthin A 
(30). Cleistanthin E is a triglycoside isolated from the plant (31). 
 
 
 
                                         Cleistanthus collinus  
Common names Oduvan, Garari, Karada, Pasu 
Botanical name Cleistanthus collinus 
Kingdom Plantae 
Phylum Tracheophyta 
Subphylum Euphyllophytina 
Class Magnoliopsida  
Subclass Rosidae 
Super order 
Order 
Botanical family 
Subfamily 
Genus 
Species  
 
Euphorbianae 
Euphorbiales 
Euphorbiaceae 
Phyllanthoideae 
Cleistanthus 
Collinus 
 
 
 
14 
 
                                                
Cleistanthus collinus has certain beneficial effects also. It has been studied for anticancer, 
hypoglycaemic, antibacterial, antiviral and diuretic effects. Water soaked with the leaves 
has been used for headache. The extract from the plant was used for gastrointestinal 
disorders. Leaf extract from Cleistanthus collinus has larvicidal property. This is used as 
manure also. The bark of Oduvanthalai contains tannin which is used in leather industry 
(32). 
Clinical profile of Cleistanthus collinus poisoning 
Mortality rate due to Cleistanthus collinus poisoning  is around 28% and the victim dies 
within 3 to 7 days of ingestion of toxin (33).Patient’s clinical features include nausea, 
vomiting, hypotension, tachycardia, breathlessness, hyperthermia etc. Laboratory 
investigation shows ECG changes (Prolongation of QT interval, ST depression and flat P 
wave) and elevation of hepatic enzymatic levels like ALP, SGPT, and SGOT, 
hypokalemia, increased urinary potassium excretion, increased urine anion gap, low 
central venous pressure, infiltrates in X- ray, low serum bicarbonate and metabolic 
acidosis (4) (6) (34). Most of them were diagnosed to have distal renal tubular acidosis, 
inappropriate vasodilatation leading to distributive shock, arrhythmia and pulmonary 
oedema that is not cardiogenic (6) (35).  
Hypotension was initially thought to be of cardiac origin but a case study by Benjamin et al 
suggests that  hypotension is secondary to vasodilatation (27) (33). There may be associated 
shock due to peripheral vasodilatation which can cause death of the patient. A recent MD 
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(Medicine) thesis from the Department of Medicine, Christian Medical College, Vellore has 
shown severe intractable hypotension presenting on the 3
rd
 - 4
th
 day with normal cardiac inotropy 
and chronotropy as demonstrated by daily echocardiography, holter and ECG monitoring. At the 
presentation of hypotension the patients had normal renal function. Nitrite levels were also 
studied daily and found to be normal. Hence it was concluded that death was due to 
inappropriate vasodilatation occurring in peripheral vessels in Cleistanthus poisoning.  
In our lab, animal experiments with whole aqueous extract of Oduvanthalai leaf showed 
similar clinical picture as seen in human cases, in terms of type I distal renal tubular 
acidosis (5). Research on this topic in our lab focuses on the mechanism of toxicity of 
Oduvanthalai poison and development of treatment options. We have isolated the 
individual fractions of Cleistanthin collinus from the whole extract by column and thin 
layer chromatography. We have also standardized extraction procedures to get two toxins 
in pure form for our experiments. The compounds have been authenticated by department 
of chemistry, IIT, Mandi. It was our collaborator at IIT, Mandi, who identified 
Cleistanthin C in the aqueous extract of Cleistanthus collinus that we had prepared. 
Structure of Cleistanthin C 
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Treatment modalities available 
The mainstay of treatment is close monitoring of patient for development of any 
complication. Electrolyte imbalance and acidosis are corrected. Renal functions are to be 
monitored closely (36). Mechanical ventilation and cardiac pacing are needed in certain 
patients. If the patients develop shock they are given crystalloids and inotropes. Possible 
antidotes are N- acetylcysteine, L- cysteine and thiol containing compounds. But the 
benefit with these compounds are unclear (27). 
Since intractable hypotension, which is supposed to be due to peripheral vasodilatation, 
can cause death of patients, our study aims at finding out the effect of Cleistanthin C on 
blood vessel. 
Figure 2: Structure of Cleistanthin C. 
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Vascular smooth muscle  
Vascular smooth muscle is present on the wall of blood vessel. This smooth muscle can 
relax and contract according to the blood volume it contains and the local blood pressure. 
It helps in the redistribution of blood within the body. Excess of vasoconstriction 
produces hypertension and vasorelaxation produces hypotension. Vascular smooth 
muscles are innervated by sympathetic nervous system primarily through adrenergic 
system. 
Vascular adrenoreceptors 
In the central as well as periphery adrenaline and noradrenaline are the main 
neurotransmitter which acts on adrenergic receptor. Ahlquist proposed the presence of 
two types of adrenergic receptors – alpha and beta in 1948. Later selective antagonists 
were discovered for these receptors. Ergotamine and phentolamine are the antagonists for 
alpha receptors and propranolol and dichloroisoprenaline for beta receptors. Beta 
subtypes were identified by Furchgott in 1967. β1 was identified in cardiac muscle and β2 
in bronchi. Alpha subtypes, α1 and α2 were discovered later. Stark gave the evidence that 
Clonidine and methacholine can activate prejunctional α receptors while phenylephrine 
and methoxamine can activate postjunctional α adrenoreceptors. Later the nomenclature 
α1 and α2 were given according to the agonists and antagonists acting on it by Berthelsen 
and Pettinger (8). 
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α1 adrenoreceptors subtypes are α1A, α1B and α1D. A fourth subtype α1L was found to be a 
conformational state of α1A. α1 adrenoreceptor acts via Gq protein to activate 
phospholipase C. Phospholipase C will convert phosphatidylinositol bisphosphate (PIP2) 
to inositol triphosphate and diacyl glycerol (DAG) by hydrolysis. Inositol triphosphate 
(IP3) will attach to IP3 receptors present in sarco/endoplasmic reticulum and cause 
calcium release from it. Diacylglycerol will activate protein kinase C (37). 
There are 3 subtypes of α2, which are α2A/D, α2B and α2C. α2 acts via Gi and inhibits adenyl 
cyclase. Adenyl cyclase helps in the conversion of ATP to cAMP and thus activates 
protein kinase A. Therefore α2 is inhibiting protein kinase A. It will inhibit voltage gated 
Ca
2+
 channel and will open up K
+
 channel. It can also act via Na/H exchanger, 
phospholipase A2, C and D (37). 
Vascular smooth muscle has both α and β adrenoreceptors. Contraction of vascular 
smooth muscle occurs mainly via α1 receptor. In veins both α1 and α2 can produce 
contraction. All subtypes of α1 contribute to vasoconstriction. In rats α1A is the 
predominant subtype that regulates blood pressure. Other subtypes are also proved to be 
present in rat arteries. α2 is reported to be present in small arterioles also. β1 and β2 are 
present in vascular smooth muscle and its activation produces vasorelaxation. Presence of 
β3 has also been reported in blood vessel which can also produce vasodilatation (38). 
Vascular endothelium contains α2 and β adrenoreceptors which can produce 
vasodilatation. Both of these act via nitric oxide release which will activate soluble 
guanylyl cyclase (sGC). sGC will convert GTP to cGMP and cGMP can activate protein 
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kinase G. Protein kinase G can produce vasodilatation by either activation of Ca
2+
 
activated K
+
 channel or activation of myosin light chain phosphatase (37). 
Noradrenalin produces vasoconstriction by acting through α1 receptor mainly. But it can 
act through α2 receptor also. It depends on the site and length of artery. In distal part there 
are more of α2 receptors than α1. Distribution of β receptors also vary with length of 
vessel. β1 receptors increases from proximal part to distal part. Both α and β receptors are 
present in large coronaries whereas small coronaries possess only β receptors (8). 
Ion channels in blood vessel 
Vascular tone of small arteries as well as arterioles determines the resistance of the 
circulation. Therefore vascular tone plays a major role in blood pressure regulation and 
blood distribution to various tissues and organs. Vascular tone depends on 
vasoconstrictor and vasodilator stimuli from neurotransmitters, circulating hormones, 
endothelium derived factors as well as blood pressure. Ion channels have a major role in 
vascular tone. Calcium produces vasoconstriction. In addition to that, ions determine 
membrane potential. Membrane potential regulates influx of calcium. Smooth muscle of 
blood vessel contains two types of calcium channels that are voltage gated, four types of 
potassium channels, store operated and stretch activated channels and two types of 
chloride channels (7). 
Potassium channels 
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Potassium channels mainly contribute to membrane potential. When the channel opens 
potassium will efflux and produces hyperpolarisation. Opposite effect is produced on 
closure of the channel. Four classes of potassium channels are present in smooth muscle 
(39). 
Noma first described KATP channel in cardiac myocyte. When ATP concentration is 
increased, this channel opens. The agonists of KATP channels like pinacidil and 
cromakalim produces vasodilatation. KATP channel antagonist glibenclamide causes 
vasoconstriction. Some of the vasoconstrictors act via Protein kinase C and produce 
closure of this channel (39) (40). 
BKCa channels are large conductance channels. These channels open by membrane 
depolarisation and by increase in calcium levels. BKCa channel antagonists like tetraethyl 
ammonium and iberiotoxin can produce vasoconstriction. This channel is activated by 
nor adrenaline and can decrease vasospasm due to norepinephrine. This channel is 
activated by certain vasodilators that act via cGMP or cAMP (7). 
Voltage gated potassium channels (KV channels) will open by membrane depolarisation. 
Vasodilators that are acting through cAMP can open this channel and certain 
vasoconstrictors can close this channel, thereby increasing intracellular Ca
2+
 to produce 
contraction. 
KIR (inward rectifier) channel was first described by Katz. K
+
 current will move inside 
through this channel.KIR maintains the resting membrane potential. Increase in 
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extracellular level of potassium produces hyperpolarisation and thereby vasodilatation. 
This may be due to Na- K ATPase activation or KIR channel activation (7). 
Calcium channels 
Voltage gated calcium channels close on hyperpolarisation causing vasodilatation. On 
depolarisation this channel will open to produce vasoconstriction. L-type calcium 
channels which are dihydropyridine sensitive are the main calcium channels present in 
the vessel. But T type calcium channels are also present in the vessel. Vasoconstrictors 
acting via Protein kinase C will activate this channel. These channels are inhibited by 
protein kinase G (41). 
When the intracellular calcium stores get depleted store operated calcium channel gets 
activated and calcium enters the cell to refill the calcium store. Calcium can enter the cell 
through stretch activated calcium channel also. Even if the voltage gated calcium 
channels are inhibited calcium can enter through these channels (7). 
Chloride channels 
Opening of this channel will cause depolarisation and thus vasoconstriction. There are 
two types of chloride channels: calcium activated and volume regulated. Similar to BKCa 
channel, calcium activated chloride channels are activated by calcium and depolarisation. 
Volume regulated calcium channels are needed to maintain the membrane potential at 
resting condition of the vessel and thus the vascular tone (7). 
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Vascular smooth muscle tone 
Blood flow is controlled by resistant arteries by changing their diameters according to the 
pressure inside the lumen. The diameter of the vessel is controlled by the vascular smooth 
muscle lining the vessel. Increase in the luminal pressure depolarizes vascular smooth 
muscle and increases Ca
2+
 level inside the cell. This increase in calcium produces 
vascular smooth muscle contraction and thus vasoconstriction (13). When isolated and 
cultured vascular smooth muscle cells are stimulated with agonists there is an intermittent 
increase in Ca
2+
 concentration intracellularly known as calcium oscillation. IP3 mediated 
Ca
2+
 release from sarcoplasmic reticulum is found to be the major mediator for the initial 
Ca
2+
 release. The frequency of calcium oscillation depends on both IP3 mediated Ca
2+
 
release and Ca
2+
 influx through plasmalemma. This intermittent rise in calcium is more 
advantageous than tonic calcium release as this intermittent form can be controlled easily.  
The oscillator is induced by ligands such as epinephrine and norepinephrine,  angiotensin 
2, thrombaxane, vasopressin and endothelin-1, which act through inositol 1,4,5-
trisphosphate (InsP3) mediated SR (sarcoplasmic reticulum) calcium release (10). 
The oscillator is dependent on Ca
2+
 entry for charging up the stores for every oscillatory 
cycle. This Ca
2+ 
entry is through Na
+
-Ca
2+
 Exchanger (NCX) in reverse mode (42) (43), 
purinergic receptor P2X which is responsible for junctional calcium transients (12) and L 
type Ca
2+
 channels (13). It can occur also through some subtypes of Transient Receptor 
Potential (TRP) ion channels like TRPC3 and TRPC7 (14) (15). 
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When vascular smooth muscle is stimulated with sympathetic system it will contract for a 
short time even without extracellular Ca
2+
. But only if there is extracellular Ca
2+
 it will 
continue to contract. This shows that extracellular Ca
2+
 is needed to maintain the steady 
tone of vascular smooth muscle. Masamitsu lino et al reported that sympathetic 
stimulation produced Calcium oscillations in vascular smooth muscle cells and it was not 
due to graded response in each of the cell but by the number of smooth muscle cells that 
are recruited. They reported that Calcium oscillation mainly depends on the intracellular 
Ca
2+
 stores. With increasing dose of Noradrenalin there was increase in Calcium 
oscillation and these oscillations were abolished by Ryanodine and caffeine which can 
deplete calcium stores. When there was no extracellular Ca
2+
 the oscillation disappeared 
after some time which shows that the Ca
2+
 influx through plasmalemma is needed for 
replenishing the intracellular Calcium stores. After stimulation with noradrenalin there 
are two phases of contraction, phasic response initially and a tonic response which is 
sustained. The phasic response is due to calcium stores inside the cell and tonic response 
is due to Ca
2+
 influx from outside (9). 
Jose. F. Perez et al reported that ACH and 5- HT can induce calcium oscillation and thus 
smooth muscle contraction. KCl produced a transient increase in Ca
2+
 and induced a 
twitching in the smooth muscle cell. Both of these required Ni2+ sensitive Ca
2+
 influx to 
refill the intracellular calcium stores. The magnitude of contraction depends on the 
frequency of oscillations (10). 
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A study done by Cheng- Han Lee on the phenylephrine mediated calcium oscillations 
showed that calcium oscillation was by release of Ca
2+
 from sarcoplasmic reticulum by 
IP3. The SR stores were replenished by sarco/endoplasmic reticulum Ca-ATPase 
(SERCA). Nifidipine is an L-type Ca
2+
 channel blocker and can decrease the calcium 
oscillations. Store operated channel/ receptor operated channel (SOC/ROC) blocker 
SKF96365 also decreased the calcium oscillations. Rest of the calcium oscillations were 
completely abolished by Na – Ca exchanger (NCX) blockers. This concludes that PE 
mediated calcium oscillation are by IP3 mediated Ca
2+
 release and SERCA replenishes 
the store. Ca
2+
 entry through NCX in reverse mode which is facilitated by Na
+
 entry 
through SOC/ ROC  as well as Ca
2+
 entry through L- type Ca
2+
 channel maintain the 
calcium oscillations (42). 
NCX can cause either entry or exit of Ca
2+
. It depends on intracellular Ca
2+
 level, 
intracellular Na
+
 level and on membrane potential. Ca
2+
 exit mode is called forward mode 
and Ca
2+
 entry mode is called reverse mode. ATP is not needed for the NCX to operate. 
Ca
2+
/ Ca
2+
 exchange can be mediated by NCX. Immunohistochemistry of NCX revealed 
that it is seen in the plasma membrane near to sarcoplasmic reticulum which shows that it 
has a role in maintaining the SR calcium store. The NCX along with ATP- driven Ca
2+
 
pump and sarcolemmal Ca
2+
 channel can change the intracellular Ca
2+
 concentration. It 
maintains the peripheral vascular resistance also. High level of Na
+
 pump inhibitor has 
been suggested as the pathogenesis of essential hypertension (44) (11). 
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Sympathetic stimulation of small artery can release neuropeptide Y, ATP and 
noradrenalin. ATP acts via purinergic receptor P2X and cause influx of Ca
2+
 and Na
+
. 
This calcium entry is called junctional calcium transient. Christine Lamont et al reported 
that P2X inhibitor suramin reduced the vascular smooth muscle constriction after 
sympathetic stimulation (12). 
Many studies showed that voltage gated L- type Ca
2+
 channel which are dihydropyridine 
sensitive are needed for global increase in intracellular Ca
2+
. L type Ca
2+
 channel blocker 
prevented the global increase in Ca
2+
 and inhibited vasoconstriction. When genetically L- 
type Ca
2+
 channels were disrupted, that also decreased Ca
2+
 intracellularly. Even 
increasing the intravascular pressure did not increase Ca
2+
 in the presence of L- type Ca
2+
 
channel blocker. Gregory C. Amberg et al performed the test for Ca
2+
 entry in vascular 
smooth muscle cell via Calcium sparklet model. There are Ca
2+
 sparklet sites through 
which Ca
2+
 influx occurs that can increase global as well as local Calcium. These sites 
can be of low activity or high activity, PKCα dependent and persistent. Ca2+ sparklet 
model states that steady state calcium influx is by opening of clusters of persistent L-type 
calcium channel along with voltage gated Ca
2+
 channel. They found that 50% of Ca
2+
 
influx occurs via high activity Ca
2+
 sparklet sites. PKC activators and L-type calcium 
channel agonists increases Ca
2+
 influx (13) . 
The initial release of Ca
2+
 is then amplified by Ca
2+
 induced Ca
2+
 release (CICR) from the 
stores by Ryanodine receptor (RyR) or InsP3 receptor( IP3R ) (16) (17).  
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There are different models of calcium oscillation. One model suggests that calcium 
oscillation depends entirely on IP3. There will be feedback mechanism to IP3 receptor that 
determines the calcium oscillation. Desensitization of IP3 receptor occurs which is 
reversible. Another model is luminal loading model. In this model when an agonist binds 
to receptor on plasma membrane, it activates the formation of IP3 from PIP2. At the same 
time agonist causes influx of Ca
2+
 and loading of sarcoplasmic reticulum. The sensitivity 
of IP3 receptor depends on Ca
2+
 load inside sarcoplasmic reticulum. When the IP3 
receptor is fully sensitized the binding of IP3 to the receptor causes Ca
2+
 release from 
sarcoplasmic reticulum. After the release is terminated the cytosolic Ca
2+
 is removed by 
three mechanisms. One is through PMCA (plasma membrane Ca-ATPase). Others are via 
SERCA (sarco/Endoplasmic reticulum Ca-ATPase) and into the mitochondria. From the 
mitochondria calcium will move out to cytoplasm and to the sarcoplasmic reticulum for 
loading in the inter spike period. This reloading helps in the next spike. The reloading 
determines the frequency at which oscillation happens. So here the luminal calcium will 
decrease as the spike is happening and then is reloaded for the next spike. This model 
shows why the Oscillation is sensitive to extracellular Ca
2+
 as it has effect on Ca
2+
 
loading in the sarcoplasmic reticulum (16). 
Haddock and Hill reported that when agonists attach to the receptor or vascular smooth 
muscle is activated by stretch, there will be release of calcium from the endoplasmic 
reticulum by the attachment of IP3 to IP3 receptor. This calcium released will activate 
Ca
2+
 dependent chloride channel and causes depolarization. This depolarization will 
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activate voltage gated calcium channel (VGCC) and release of Ca
2+
 from ryanodine 
stores. This will activate intermediate conductance Ca
2+
 dependent potassium channel to 
produce hyperpolarisation and relaxation of vessel. As the ryanodine stores are 
inactivated IKCa channel closes and opens up VDCC to produce contraction and the cycle 
will repeat. Gap junctions help in spreading depolarization causing Ca
2+
 influx via VDCC 
to cause Ca
2+
 release from ryanodine stores to produce the calcium oscillation. They 
showed that calcium oscillations became asynchronous with removal of endothelium but 
the amplitude of oscillations is not affected. They used BAPTA- AM which is a calcium 
chelator and thapsigargin which is an inhibitor of Ca- ATPase. Both these inhibited 
calcium oscillations.U73122 which is a phopholipase C antagonist will prevent IP3 
formation. U73122 also inhibited calcium oscillations. When ryanodine was added, it 
enhanced the frequency of oscillation and decreased the amplitude. This shows that 
ryanodine is needed not for initiating vasoconstriction but to produce hyperpolarisation 
and thus negative feedback in the oscillations.  NFA and DIDS which are calcium 
dependent chloride channel antagonists inhibited the oscillations and contractions. 
Inhibition of SKCa, BKCa channels and Kv channel did not inhibit calcium oscillations. In 
the presence of TRAM-34 which is a specific inhibitor of IKCa channel decreased the 
amplitude of oscillations, but increased frequency (45). 
The global increase in Ca
2+
 will activate contraction. Ca
2+
 will combine with a protein 
known as calmodulin to form Ca
2+
- calmodulin complex. This complex will activate 
myosin light chain kinase. Myosin light chain kinase phosphorylates myosin head and 
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increases myosin ATPase activity. The activated myosin light chain can slide along the 
actin filament to produce contraction. Another effect of increased Ca
2+
 is to stimulate 
Ca
2+
 sensitive Cl
-
 channels (21). This causes membrane depolarisation and enhances 
opening of L type Ca
2+
 channels, leading to further depolarisation.  
The relaxation phase depends mainly on Sarco/Endoplasmic Reticulum Ca
2+
 ATPase 
(SERCA), Plasma Membrane Ca
2+
 ATPase (PMCA) and NCX in forward mode that is 
coupled to Na-K ATPase which decreases the cytosolic Ca
2+
 (18) (19). 
There are four isoforms of PMCA of which PMCA2b is not seen in smooth muscles of 
blood vessels. It is a housekeeping calcium pump. It can produce signal transduction and 
smooth muscle cell proliferation also. Activation of PMCA will decrease the SERCA 
action. But increase in Ca
2+
 can activate both SERCA and PMCA. PMCA contributes 
about 75% Ca
2+
 clearance in uterine smooth muscle. But in vascular smooth muscle it 
contributes only 23%. Only two isoforms of SERCA namely SERCA2a and SERCA2b are 
seen in vascular smooth muscle. It was shown that 50% reduction of SERCA activity by 
genetic control did not change the vasoconstriction by phenylephrine or KCl. But when 
SERCA is inhibited by phospholamban it can affect the vascular smooth muscle 
contraction. NCX in forward and reverse mode are also needed for maintaining normal 
vascular tone. NCX in forward mode along with NKA produces vasoconstriction, 
whereas in reverse mode it produces vasodilatation. When NCX was inhibited by methyl 
glucosamine, it inhibited phenylephrine mediated contraction. There are three isoforms of 
NCX. NCX 1.1 is the only one present in heart. NCX 1.3 as well as NCX1.7 is seen in 
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smooth muscle. α- NKA are also of 4 isoforms. α1 and α2 subunits are seen in mouse 
vessels. Mice having α1 are normotensive and those with α2 are hypotensive (44). 
One effect of increased global Ca
2+
 is to stimulate Ca
2+
 sensitive K
+
 channels (BK and 
SK) which cause membrane hyperpolarisation. Myosin phosphatase can dephosphorylate 
myosin light chain phosphate and will produce vasodilatation (20). 
Ca
2+
 oscillation also depend on ATP. ATP is released from vascular smooth muscle cells 
through membrane transporters, ABC transporters and channels including connexion 
hemi channel, pannexin channel. ATP acts via purinergic receptors P2X and P2Y. ATP 
will act on P2X receptor to produce vasoconstriction and P2Y receptor to produce 
vasodilatation (21). 
Earlier ATP was considered as an energy source alone which is produced by 
mitochondrial ATP synthase. After being produced in mitochondria they are transported 
to cytosol and stored there. But later it was found that ATP is released by different cells 
and acts as signalling molecule. Burnstoke gave the name purinergic for the nerves that 
secrete ATP and not adrenalin or Acetylcholine. ATP signalling is seen everywhere in the 
vasculature. Williams and Forrester found that ATP is released by cardiac cells as well as 
by all components of vasculature like smooth muscle cells, endothelium, erythrocytes and 
perivascular nerves (21). 
 Drury and Szent-Gyorgyi were the first to observe purinergic signaling in vascular 
smooth muscle. They produced hypotension and sinus bradycardia in dogs by injecting 
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adenine nucleotides. Later purinergic receptors were discovered in the vascular smooth 
muscle and in the endothelium. Purinergic receptors are classified into P1 and P2. P1 is 
again classified into A1, A2 (A2A and A2B) and A3. All of these are G protein coupled 
receptors Gs or Gi which modulate cAMP levels in the cell. P2 consists of P2X and P2Y. 
P2X are ionotropic and contain seven isoforms. P2Y receptors are metabotropic and 
include 8 isoforms. When ATP binds to P2X receptor it can open up channels to cause 
influx of Na
+
 or Ca
2+
. This causes depolarization of the cell and further influx of Ca
2+
 to 
produce vasoconstriction. P2Y can activate Gq, Gi or Gs. Although there are many P2X 
receptors the main one is the P2X1 which produces vasoconstriction. When ATP binds to 
P2Y receptors present in the endothelium it activates G protein to activate IP3 mediated 
Ca
2+
 release. This will activate endothelial nitric oxide synthase to produce nitric oxide 
which will produce vasodilatation. It has also been shown that ATP can produce 
vasodilatation by acting through P2X receptors on endothelium and constriction by acting 
through P2Y receptors on smooth muscle (21).  
Ectonucleotidases cause breakdown of ATP to ADP and AMP. One of the main 
ectonucleotidases is E- NTPDases or CD39. CD39 can decrease the amount of ATP, 
UTP, ADP, and ADP in the cell for binding to receptor and thus decrease the 
vasoconstriction. This shows that purines and ectonucleotidases have a role in peripheral 
resistance and blood vessel. ATP is increased during hypoxia and ischemia. It causes 
vasodilatation and increases oxygen supply. ATP is released from perivascular nerve 
which acts through P2X1 receptor to produce vasoconstriction (21).  
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ATP is released mainly by vesicular exocytosis. Proteins that are synthesized in the 
endoplasmic reticulum are processed in the Golgi apparatus and then fuse with plasma 
membrane. When tetrodotoxin which is Na channel blocker needed for exocytosis was 
added, it inhibited ATP release from nerve terminal. The vesicular transporter was found 
to be VNUT that pumps ATP into vesicle by using the proton gradient built by vacuolar 
ATP-ase. Activation of sympathetic nerve produces a fast contraction initially followed 
by a slow sustained contraction. ANAPP3 which is an inhibitor of P2 receptor prevented 
the initial fast contraction part and adrenergic inhibitor prevented the sustained 
contraction part (21).  
ABC is another set of ATP transporter that transports ATP from the cell outward. CFTR 
is an ABC transporter which activates protein kinase A via cAMP which causes the 
release of ATP. Glibenclamide and niflumic acid inhibit CFTR gene and thus ATP 
release. SUR is another ABC transporter. It produced depolarization by inhibiting KATP 
channel. Plasma membrane F1F0ATPase synthesizes ATP by using the proton gradient 
produced by mitochondrial phosphorylation. F1 subunits catalyze the phosphorylation of 
ADP to ATP. F0 subunit helps in the anchoring of protein to the pore for transport. 
Connexin are proteins that form gap junctions. Connexin of adjacent cells form a gap 
junction through which ATP can be transported outward. Normally this hemichannel will 
be closed. Only conditions like decrease in calcium concentration, depolarization etc will 
open up this channel. Flufenamic acid inhibiting connexon channel inhibit ATP release 
also. Four isoforms of connexon channels are identified in blood vessel which includes 
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Cx45, Cx40, Cx37 and Cx43. Pannexin channel is another channel that helps in the 
transport of ATP. But unlike connexin they won’t form gap junctions and so are not 
hemichannels. There are three isoforms of pannexin channels. Carbenoxolone which is a 
pannexin channel inhibitor prevents ATP transport via pannexin channel. Pannexin 
inhibitors like mefloquine and probenecid decreases the vasoconstriction by 
phenylephrine which is an alpha-1 agonist. This shows that ATP release via pannexin 
channel is essential for adrenergic vasoconstriction (21). 
Any change in this normal calcium oscillation, may be a cause for vasodilatation that 
occurs in Cleistanthus collinus poisoning. 
Vasodilatation can also occur due to dephosphorylation of myosin light chain. Nitric 
oxide (NO) is one of these kinds. Nitric oxide is produced constitutively in the 
endothelium by NO synthase from L- Arginine. There are three forms of NO synthase 
which include nNOS, iNOS and eNOS. Of these eNOS is present in the endothelium. 
Nitric oxide can activate guanylyl cyclase which converts GTP to cGMP. cGMP can 
activate protein kinase G (PKG).  PKG phosphorylates myosin light chain kinase. This 
phosphorylated myosin light chain kinase is in inactive form. Inactivated myosin light 
chain kinase can dephosphorylate myosin light chain to produce vasodilatation. NO is 
considered as the endothelium derived relaxing factor (EDRF) (22). NO has also been 
proven to act in a cGMP independent manner via Ca
2+
 dependent potassium channel 
activation (46) and activating reuptake of calcium into sarcoplasmic reticulum (47).  
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In the presence of excess NO like eNOS activators, sGC inhibitors or cGMP 
phosphodiesterase inhibitors, phenylephrine, which is an alpha agonist, can produce 
vasodilatation (paper published by same authors) (23).  
Vasodilatation in Cleistanthin collinus poisoning may also be due to NO release or 
cGMP phosphodiesterase inhibition which increases cGMP levels.  
Total peripheral resistance 
Cardiovascular system consists of heart and two circulatory systems – systemic 
circulation and pulmonary circulation. Systemic circulation takes oxygenated blood from 
heart to all parts of our body and deoxygenated blood to heart. Similarly pulmonary 
circulation carries deoxygenated blood from heart to lung and oxygenated blood from 
lungs to heart. Systemic circulation consists of aorta, arteries, arterioles, capillaries, 
venules and veins. Blood is pumped into aorta from heart during systole. Compliance of 
aorta is high and accommodates the blood in it. During diastole, recoil of aorta will cause 
the flow of blood to the periphery. Compliance of the arterial system decreases from 
aorta to capillaries. So the pressure pulsation reduces to almost nil by the time it reaches 
the capillaries. The highest pressure of the cardiac cycle occurs during systole and is 
called systolic pressure. The lowest pressure of the cardiac cycle occurs during diastole 
and is called as diastolic pressure. Pulse pressure is the difference between these 
pressures. Mean arterial pressure is the average pressure over a period of time. It is not 
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the average of systolic and diastolic pressure as greater part of cardiac cycle is in diastole 
(24).  
Blood flow is the amount of blood passing through a point in circulation at a given time. 
Blood flow depends on two factors: 
1. Pressure difference between the two ends of vessel. 
 2. Vascular Resistance. 
Flow = ∆P / R                                                                                                                                                                                                                                                                                                                                                                                                                    
Vascular resistance is due to friction of blood while flowing through a vessel. It gives 
impedance to the blood flow. It cannot be measured by direct means. It is calculated from 
blood flow and pressure difference. 
R=∆P / Flow                                                                                                                                                                                                                                                                                                                                                                                                                   
If the flow is 1 ml/sec and pressure gradient is 1mmHg, resistance is called 1 PRU i.e. 1 
peripheral resistance unit. Unit of resistance is dyne sec/cm
5
. 
R(in dyne sec/cm5) = 1333xmmHg/ml/sec. 
According to Poiseuille’s law, F= π∆pr4/8ηl, where 
F=rate of blood flow 
∆p=pressure difference between end of vessels 
r=radius of the vessel 
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η=viscosity of blood 
l=length of the vessel. 
From this resistance can be calculated as, R = 8ηl/πr4. Therefore the resistance is 
inversely proportional to the fourth power of radius. Even a small decrease in radius will 
cause very large increase in resistance. 
Blood that is pumped from heart will pass through aorta, arteries, arterioles, capillaries, 
venules, veins and lastly back to heart. All these are arranged in series and therefore the 
resistance of total systemic circulation is the sum of the resistance of each vessel. 
R total = R1+R2+R3...  
Blood flow to different organs is arranged parallel and so can regulate their own blood 
supply. For these vessels arranged in parallel total resistance is calculated as 1/R total = 
1/R1 + 1/R2 + 1/R3... So the total resistance will be less than the resistance of single 
vessel.  
Total peripheral vascular resistance is the resistance of entire systemic circulation. Taking 
cardiac output as 100 ml/sec and pressure difference between systemic arteries and veins 
as 100 mmHg the TPR can be calculated as 100/100 or 1 PRU. 
Therefore TPR can be expressed as Mean Blood Pressure / Cardiac output, where Cardiac 
Output is the amount of blood pumped by heart for a specific duration and mean blood 
pressure is the average pressure during that time (24). 
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Rat hind limb method 
 
Ruderman first developed the rat hind limb model in 1971 (48). This method is peculiar 
as it can control the rate as well as content of perfusion. There are different methods in rat 
hind limb preparation which include double hind limb with trunk, single hind limb, 
double hind limb and distal hind limb alone. Here we have used the double hind limb 
with lower part of trunk (49). 
Rat hind limb model is used widely in exercise physiology to study muscle metabolism. 
In this model oxygen supply can be controlled and specific compounds can be added to 
see their specific effect on muscle metabolism (49). This model is also used to study the 
pharmacokinetics of various drugs (50). 
In hind limb preparation, arteries and arterioles are intact as if in a living animal where as 
in isolated vessel experiment we get the vascular tone from a single vessel. There won’t 
be any neural reflexes from central nervous system in this model so that the changes with 
the interventions will be vascular alone. We can calculate the actual peripheral resistance 
from the blood pressure and flow rate.   
Peristaltic pump  
A Peristaltic pump was used in the study which can replace the heart pulsatility. The 
pump used in the study has one rotor which has six rollers. The rollers will compress a 
rubber tube to push the fluid out. 
37 
 
 
 
The roller will push a constant fluid amount with each rotation. Thus the roller is similar 
to heart with cycle rate as heart rate and flow rate as stroke volume. Flow rate of the 
peristaltic pump in ml/min is calculated as cycle rate multiplied by beat flow rate. Flow 
rate in one beat of the peristaltic pump is a constant which is 120µl/ beat. 
Dr Benjamin Jebaraj, in our department derived an algorithm to estimate resistance in a 
rat hand limb preparation. The Windkessel model was used to derive beat to beat change 
in resistance.  
Figure 3: The peristaltic pump used for the experiments. 
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Windkessel model was developed by Stephan Hales for arterial system in 1773. 
Windkessel means air chamber in German. These were used to give pulsatile flow in fire 
engines. When flow is there water will fill the chamber and when flow stops the filled 
water will flow from chamber and thus give a continuous flow. In cardiovascular 
Windkessel model the arterial system is considered as a single segment. During systole 
blood is stored in large arteries. During diastole when blood is not coming from heart 
blood stored in large arteries are ejected by elastic recoil. Thus throughout cardiac cycle 
there will be blood flow. Two element Windkessel model contains two parameters, 
resistance and compliance.  It is similar to an electric circuit with resistor and capacitor 
connected in parallel. 
 Flow rate through the resistance blood vessel is QR = P, where P is the pressure in the 
aorta and R is the resistance. 
Flow rate through the capacitance blood vessel is QC = dVc = C dp , where Vc is the flow  
through blood vessel, C is compliance and P is the aortic pressure. 
Total flow through the arterial system is 
Q = QR + QC or  
 
The Windkessel equation is Q =P (t)   + C dP (t) 
 
R dt 
     R 
dt dt 
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Of these; pressure is directly measured and flow is known from peristaltic pump. To get 
the values of resistance and compliance algorithm by Levenberg – Marquardt was used. 
Flow curve is used as input and the algorithm will substitute values for R and C and will 
derive the pressure curve. The values for R and C which gives the best fit for pressure 
curve will give the values of the parameters. The resistance in rat hind limb preparation in 
this study was derived by the above algorithm developed by Dr Benjamin Jebaraj. 
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MATERIALS AND METHODS 
 
Materials required for the isolation of Cleistanthin C 
1. Shade dried leaves of Cleistanthus collinus 
2. Silica 
3. Conical flask 
4. Chloroform 
5. Distilled water 
6. Hot plate 
7. Glass petridishes 
8. Weighing machine 
9. Wire mesh 
10. Funnel  
11. Hot air oven 
12. Ethanol 
13. N- Heptane 
14. Methanol  
15. Filter paper 
16. Thin layer chromatography tanks and plates 
17. UV illuminator 
18. Shimadziu HPLC system 
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Materials required for isolated hind limb preparation 
1. Wistar rats 
2. 24 G cannula 
3. Scissors – straight and curved 
4. Artery forceps – straight and curved 
5. Forceps 
6. Bone cutter 
7. Spatula  
8. 3 way stop cock 
9. Cotton 
10. Adhesive  
11. Suture thread 
12. White board 
13. Petridishes  
14. 1 ml syringes  
15. Peristaltic pump 
16.  Langendhoff apparatus 
17. Pressure transducer 
18. Pressure amplifier 
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19. CMC daq – Data acquisition system developed by Department of Bioengineering, 
CMC 
20. Laptop  
 
 
Solutions 
Ketamine – 100mg/kg body of weight 
Xylazine – 1.87mg/kg body of weight 
Heparin 
Phenylephrine 
Nor adrenaline 
Figure 4: CMC data acquisition system (CMC Daq). 
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Adrenaline  
 
 
 
Normal extracellular solution 
         NaCl          100mM/L 
         KCl              3mM/L 
         CaCl2              1.3mM/L 
       NaH2PO4           0.5mM/L 
       Na2HPO4             2mM/L 
       NaHCO3             25mM/L 
         MgCl2              2mM/L 
         Hepes              10mM/L 
Figure 5: Pressure transducer and amplifier used for recording. 
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         Glucose             5mM/L 
       Dextran               3% 
 
pH was maintained at 7.4 using 1M NaOH. 
Dextran was used to maintain oncotic pressure. 
 
Methods 
Isolation of Cleistanthin C 
 
Extraction of boiled extract 
Cleistanthus collinus leaves were collected from Palamathi hills. 100 grams of these 
leaves were boiled with 2.5 L of distilled water. Boiled extract were filtered using wire 
mesh. It was kept undisturbed for 24 hrs. Supernatant was taken for liquid – liquid 
partition chromatography. Supernatant was mixed with chloroform of about 2 L and was 
allowed to stand for few minutes so that the bottom fraction contains the chloroform with 
the fluorescent compounds. These fluorescent compounds are the active constituents and 
they can dissolve in chloroform. This bottom fraction was separated using a funnel. This 
chloroform fraction was taken in a petridish and was allowed to dry at 37
o
C in a hot air 
oven for 24 hrs. After drying the extract was collected by scraping it out from the 
petridish. In this extract thin layer chromatography was done. 
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Separation of compounds from boiled extract 
Thin layer chromatography 
a. Preparation of TLC plates 
Silica gel was prepared by mixing 40 g of silica with 80 ml of distilled water (1:2 ratio). 
The slurry prepared was poured in a spreader and was layered on a glass plate at a 
thickness of about 0.5 mm. It was kept at 110
o
C for 30 minutes for activation. This silica 
layer would act as the stationary phase.  
b. Running the TLC 
 
Figure 6: Liquid / Liquid partition chromatography. (a) Separating funnel contains 
two immiscible layers. Top layer is aqueous and the bottom is Chloroform layer. (b) 
Separated aqueous and Chloroform extract. 
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1 mg of the extract was dissolved in chloroform to get a concentration of 10 µL and was 
spotted on the bottom of the silica plate about 1.5 cm above the base. Mobile phase used 
for TLC consists of chloroform, n- Heptane and ethanol in the ratio of 50: 50: 10. This 
solvent was poured into TLC tank. TLC plates were kept inside the tank and ensured that 
the solvent touches the silica plate but not the spotted extract. When the solvent rise up 
by capillary action to about a height of 10 cm the plate were taken out. The plates were 
visualised under UV illuminator at 352 nm.  
 
 
 
The fluorescent bands in the TLC plates would in the ascending order of Cleistanthin C, 
diphylline, compound 3 (unidentified) and Cleistanthin A.  
 Figure 7: Thin layer chromatography 
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Extraction of Cleistanthin C 
Cleistanthin C band was taken into a conical flask and was dissolved in methanol. It was 
allowed to stand for some time for the silica to settle down. Supernatant was taken in a 
centrifuge tube and was centrifuged at 2400 rpm for 10 minutes to separate the remaining 
silica gel. After centrifugation the supernatant was passed through a filter paper to one 
petridish and was kept for drying at 37
o
C. Similarly six to eight washes were given and 
the supernatant was collected and dried. The dried compound (Cleistanthin C) was 
scraped from petridish and was stored at room temperature. 
 
 
 
Confirmation of Cleistanthin C by HPLC 
High performance liquid chromatography was done for the chloroform fraction and 
identified the major peaks with fluorescence detector. Shimadziu HPLC was used to 
perform the reverse phase high performance liquid chromatography. The mobile phase in 
Cleistanthin C 
Figure 8: Representation of Thin layer chromatogram for chloroform fraction. 
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the HPLC was methanol 70%. Excitation wavelength was 322nm and emission 
wavelength was 440nm. Flow rate was 1ml/min and was run for 15 min. 
 
 
 
Purity of Cleistanthin C was confirmed by a single peak in HPLC. The purity was 
confirmed by chemists from IIT, Mandi also. 
Figure 9: Shimadzu HPLC system with a fluorescence detector. 
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Isolated hind limb preparation 
 
Male Wistar rats weighing between 270 – 300 grams were used in the study. These rats 
were taken from the animal house at CMC, Vellore. Rats were administered ketamine at a 
dose of 100 mg/kg body weight and xylazine at a dose of 1.87 mg/kg body weight 
intraperitoneally to anaesthetise. Anaesthesia was confirmed by pinching the sole of the 
rat. Rat was restrained on a dissection board. Limbs were fixed with adhesive. Skin over 
abdomen of the rat was wiped with cotton soaked in distilled water. A vertical incision 
was made from xiphisternum up to pubic area to expose abdominal cavity. Skin and 
Figure 10: TLC chromatogram (a) and HPLC chromatogram (b) showing the 
purity of Cleistanthin C 
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muscle layers were incised and retracted laterally. For the better visualization of vessel 
bowel was taken out. To prevent the leaking of faecal matter the ends of bowel were 
ligated with thread. Abdominal aorta was identified above the lumbar region of vertebra. 
Connective tissue and fat around the vessels were removed to get the vessel.  
Cannulation has to be done in the abdominal aorta distal to renal artery and proximal to 
iliac artery bifurcation. A spatula was kept under this region of aorta. Apply a ligature on 
the proximal part of aorta. Ligate the abdominal aorta and inferior vena cava proximal to 
the first ligature to avoid bleeding during transaction. After the ligation trunk of the rat 
was transacted proximal to ligatures using bone cutter and the upper half of the body was 
removed. Cannulate the abdominal aorta using 24G cannula which was flushed with 
heparin. Ligate the distal end of aorta with the cannula to fix it in the place. Inferior vena 
cava was opened for the effluent to flush out. The aorta was flushed with heparinised 
extracellular fluid using a syringe till the effluent become clear. After that the cannula 
was connected to the tube from peristaltic pump. The line was also connected to pressure 
transducer and CMC Daq which would record the blood pressure on a computer.  
Modified Langendenhoff method was used to perfuse the hind limb. Two or three 
reservoirs were used. The perfusate was kept at 37
o
C and was gassed with carbogen (95% 
oxygen + 5% carbon dioxide as bicarbonate is present in the extracellular fluid). 
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Solutions required for experiments 
 
All the salts used to prepare extracellular solution were bought from SIGMA. 
Phenylephrine, Adrenaline and Noradrenalin were obtained from the hospital store, 
CMC, Vellore.  
Cleistanthin C 
Molecular weight is 702.66 gm. 
Stock solution:  
3.5 mg in 500µL of ethanol – 10mM stock solution 
Reservoirs 
Hind limb preparation 
Peristaltic pump 
CMC Daq 
Pressure transducer 
Pressure 
amplifier 
Figure 11: Model of infusion setup 
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500µL of 10mM stock solution of Cleistanthin C was added to 50 ml of extracellular 
fluid to get a final concentration of 100µM. 
In another set of experiments Cleistanthin C 500µM concentration was used. 
17.5 mg of Cleistanthin C was diluted in 30% ethanol and this was added to 50 ml of 
extracellular fluid to get a final concentration of 500µM. 
Phenylephrine 
Molecular weight is 203.67 g. 
Phenylephrine ampule contains 10 mg of phenylephrine in 1 ml. 
Therefore molarity of the stock solution is 50mM. 
20 µL of 50mM stock solution of Phenylephrine was added to 100 ml of extracellular 
fluid to get a final concentration of 1 µM. 
Adrenaline 
Molecular weight is 333.29 g. 
Adrenaline ampule contains 1mg of adrenaline in 1 ml. 
Therefore molarity of stock solution is 3mM. 
500µL of 3mM stock solution of adrenaline was added to 100 ml of extracellular fluid to 
get a final concentration of 15 µM. 
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Nor adrenaline 
Molecular weight is 169.1778 g. 
Nor adrenaline ampule contains 1mg of nor adrenaline per ml. 
So the molarity of the stock solution is 6mM. 
200µL of 6mM stock solution was added to 100ml of extracellular fluid to get a final 
concentration of 12µM. 
Experiment protocol 
Isolated hind limb preparation was perfused with extracellular fluid until it is stabilized. 
The rate of the perfusion pump was fixed at 4ml/min. In the study the Wistar rats were 
divided into three groups. Each group had twelve rats. Of these six were tests and six 
were controls. In all the three groups test rats were perfused with Cleistanthin C 100µM 
for 20 – 30 minutes and control rats were perfused with ethanol. Ethanol was used in 
control rats as Cleistanthin C was dissolved in ethanol for test group. In control group 
30% ethanol was used. In the first group, after perfusing with either 100 µM Cleistanthin 
C (in test rats) or ethanol (in control rats) for 20 to 30 minutes, phenylephrine 10 µM was 
perfused for 10 minute. After 10 minutes the hind limb was perfused with normal 
extracellular fluid. In the second and third group, in the place of phenylephrine, 
adrenaline and nor adrenaline were used respectively. In another set of experiment 
Cleistanthin C 500µM was used. After 500 µM of Cleistanthin C, Phenylephrine 10 µM 
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was perfused to confirm the results with 100 µM Cleistanthin C. The pressure changes 
throughout the experiment were recorded using a pressure transducer connected to CMC 
Daq to a laptop. Resistance changes were calculated later using a software developed by 
Dr. Benjamin Jebaraj.   
 
Figure 12: Infusion setup 
 
For analysis of wave, software written using Python was used. Data was recorded in 
CMC Daq at a frequency of 1000 Hz. Data was loaded into the program to do analysis. 
The recorded data was filtered using a low pass filter to remove noise. Peaks and troughs 
in the whole data were identified. Peaks represent the systolic blood pressure and troughs 
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represent the diastolic blood pressure. Pressure wave and the flow waves were curve 
fitted using Levenberg–Marquardt algorithm. The equation for analysis was  
𝑑𝑃
𝑑𝑡
=  
𝑄(𝑡)
𝐶
−  
𝑃(𝑡)
𝑅 × 𝐶
 
𝑃(𝑡) = Pressure  
𝑄(𝑡) = Flow rate  
𝑑𝑃
𝑑𝑡
 = Change in pressure with time 
R = Resistance 
C = Compliance 
Using the curve fitting resistance and compliance were obtained. Resistance obtained by 
this method was used to compare the test and control. 
STATISTICAL ANALYSIS 
 
Vascular resistance before and after addition of a drug were compared within a group 
using Wilcoxon signed rank test. Vascular resistance subsequent to administration of a 
particular drug in the presence of Cleistanthin C were compared with the effect of the 
same drug on vascular resistance in the control group (which was incubated with ethanol) 
using Mann-Whitney U test. P value <0.05 was considered significant. 
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RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abdominal aorta was cannulated and was connected to 
pressure transducer and CMC Daq (n=36) 
Isolated hind limb preparation of Wistar rats   
Group 3 (n=12) 
Perfused with normal extracellular 
solution and pressure was recorded 
 
Group 2 (n=12) 
Perfused with normal extracellular 
solution and pressure was recorded 
 
Group 1 (n=12) 
Perfused with normal extracellular 
solution and pressure was recorded 
 
Control (n=6) 
Perfused 
ethanol for 30 
min & 
pressure was 
recorded. 
 
Intervention 
(n=6) 
Perfused 
Cleistanthin C for 
30 min & pressure 
was recorded 
 
Control (n=6) 
Perfused 
ethanol for 30 
min & pressure 
was recorded 
 
Intervention 
(n=6) 
Perfused 
Cleistanthin C 
for 30 min & 
pressure was 
recorded 
 
Control (n=6) 
Perfused 
ethanol for 30 
min & pressure 
was recorded. 
 
Intervention 
(n=6) 
Perfused 
Cleistanthin C for 
30 min & 
pressure was 
recorded 
 
Perfused noradrenaline 12μM & 
change in pressure was recorded 
 
Perfused adrenaline 15μM & change in 
pressure was recorded 
 
Perfused phenylephrine 10μM and 
change in pressure was recorded 
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Figure 13: Detailed diagrammatic algorithm of the study. 
Pressure was recorded in CMC Daq software at 1000 Hz frequency. The recordings that 
were saved as text file were analysed later to determine the resistance. 
 
     
Figure 14: CMC Daq blood pressure recording. 
Pressure recorded from all the three 
groups 
 
Computed the vascular resistance 
offline and analysed the change in 
vascular resistance before and after 
addition of drugs by Wilcoxon signed 
rank test and between intervention 
group and control group using Mann-
Whitney U test 
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 Fitted curve was derived using flow and the resistance and compliance were derived by 
using least square method. 
 
         Figure 15: The fitted wave and the pressure wave.  
Effect of Cleistanthin C on vascular resistance 
Isolated hind limb preparation was perfused with extracellular salt solution and the 
pressure recording was done using pressure transducer connected to CMC Daq. After the 
pressure got stabilised (usually 10- 15 minutes) Cleistanthin C 100µM or 500 µM was 
perfused for 20 - 30 minutes and the pressure was recorded. Later the data was converted 
to text file and was analysed using Python software and the resistance was derived. 
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Cleistanthin C 100µM did not produce any change in vascular resistance. The vascular 
resistances before and after addition of Cleistanthin C 100µM are 10.6±5.1 and 9.2±2.4 
mmHg.min/ml respectively. 
 
Figure 16: Representative data showing blood pressure recording before and after 
addition of 100 µM Cleistanthin C.  
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Figure 17: Representative data showing mean blood pressure before and after 
addition of Cleistanthin C 100µM. 
 
 
Figure 18: Representative data showing resistance before and after addition of 
Cleistanthin C 100µM. 
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Cleistanthin C 500µM increased vascular resistance from 18.25±7 to 58.5±6.6 
mmHg.min/ml. 
 
Figure 19: Representative data showing blood pressure before and after addition of 
Cleistanthin C 500 µM  
 
Figure 20: Representative data showing mean blood pressure before and after 
addition of Cleistanthin C 500 µM  
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Figure 21: Representative data showing resistance before and after addition of 
Cleistanthin C 500 µM  
Effect of ethanol in vascular resistance 
In control group ethanol 30% was perfused and change in pressure was recorded. From 
the recorded pressure, resistance was calculated. Resistance was not changed after 
addition of ethanol. Resistance before and after addition of ethanol are 17.4±8.9 and 
14.8±10.6 mmHg.min/ml respectively. 
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Figure 22: Representative data showing blood pressure recording before and after 
addition of ethanol in control group. 
Figure 23: Representative data showing mean blood pressure recording before and 
after addition of ethanol. 
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Figure 24: Representative data showing resistance before and after addition of 
ethanol. 
 
Figure 25: Bar diagram comparing changes in resistance as percentage of baseline 
tension after addition Cleistanthin C100 µM, Cleistanthin C 500µM and ethanol. 
* 
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Effect of Adrenaline in the presence of Cleistanthin C 
In the presence of Cleistanthin C adrenaline increased the pressure and resistance. The 
resistance was increased from 8.75±6.4 to 30.5±16 mmHg.min/ml. 
 
 
 
Figure 26: Representative data showing blood pressure after addition of Adrenaline 
15µM in the presence of Cleistanthin C 100µM. 
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Figure 27: Representative data showing mean blood pressure change after addition 
of Adrenaline 15µM in the presence of Cleistanthin C 100µM. 
 
Figure 28: Representative data showing resistance after addition of Adrenaline 
15µM in the presence of Cleistanthin C 100µM. 
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Effect of Adrenaline in the presence of Ethanol 
       In the presence of ethanol adrenaline increased the pressure and the vascular 
resistance. The resistance increased from 17.3±16.5 to 35.3±13.8 mmHg.min/ml. 
 
 
Figure 29: Representative data showing blood pressure change after addition of 
Adrenaline 15µM in control group. 
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Figure 30: Representative data showing mean blood pressure change after addition 
of Adrenaline 15µM in control group. 
 
Figure 31: Representative data showing resistance change after addition of 
adrenaline in control group.  
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Figure 32: Bar diagram comparing the change in resistance after addition of 
adrenaline as percentage of resistance in the presence of either Cleistanthin C (test) 
or ethanol (control). 
Effect of Noradrenaline in the presence of Cleistanthin C 
In the presence of Cleistanthin C noradrenaline increased the resistance from 7.2±1.5 to 
25.7±8.5 mmHg.min/ml. 
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Figure 33: Representative data showing blood pressure change after addition of 
noradrenaline in the presence of Cleistanthin C. 
 
 
 
Figure 34: Representative data showing mean Blood pressure change after addition 
of noradrenaline in the presence of Cleistanthin C. 
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Figure 35: Representative data showing resistance change after addition of 
noradrenaline in the presence of Cleistanthin C. 
 
Effect of Noradrenaline in the presence of Ethanol 
In the presence of ethanol noradrenaline increased the vascular resistance from 13.6±6 to 
26.6±9.8 mmHg.min/ml. 
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Figure 36: Representative data showing blood pressure change after addition of 
noradrenaline in the presence of Cleistanthin C. 
 
Figure 37: Representative data showing mean blood pressure after addition of 
noradrenaline 12µM in control group. 
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Figure 38: Representative data showing resistance change after addition of 
Noradrenaline in control group. 
 
 
Figure 39: Bar diagram comparing the change in resistance after addition of noradrenaline 
as percentage of resistance in the presence of either Cleistanthin C (test) or ethanol 
(control). 
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Effect of Phenylephrine in the presence of Cleistanthin C 
In the presence of Cleistanthin C Phenylephrine increased pressure. The resistance was 
increased from 11.7±3.4 to 33.3±5.8 mmHg.min/ml. 
 
 
Figure 40: Representative data showing blood pressure after addition of 
Phenylephrine 10µM in the presence of Cleistanthin C 100µM. 
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Figure 41: Representative data showing mean blood pressure after addition of 
Phenylephrine 10µM in the presence of Cleistanthin C 100µM. 
 
Figure 42: Representative data showing resistance after addition of Phenylephrine 
10µM in the presence of Cleistanthin C 100µM. 
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Figure 43: Representative data showing resistance after addition of Phenylephrine 
10µM in the presence of Cleistanthin C 500µM (n=2). 
 
Effect of Phenylephrine in the presence of ethanol 
In the presence of ethanol phenylephrine increased the pressure and the resistance. The 
vascular resistance increased from 13.4±9 to 29±18 mmHg.min/ml. 
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Figure 44: Representative data showing blood pressure after addition of 
Phenylephrine 10µM in the presence of ethanol. 
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Figure 45: Representative data showing mean blood pressure after addition of 
Phenylephrine 10µM in the presence of ethanol. 
 
 
Figure 46: Representative data showing resistance after addition of Phenylephrine 
10µM in the presence of ethanol. 
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Figure 47: Bar diagram comparing the change in resistance after addition of 
phenylephrine as percentage of resistance in the presence of either Cleistanthin C 
(test) or ethanol (control). 
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DISCUSSION 
 
Cleistanthus collinus is a poisonous plant containing many toxic as well as non toxic 
components. Of these Cleistanthin A and Cleistanthin C are the main toxic components. 
Boiled extract is the most poisonous form and Cleistanthin C is main toxic compound in 
this. The research works going on in our department is to find out the mechanism of 
action of this poison.   
Hypotension leading to shock is one of the main clinical features of Cleistanthus collinus 
poisoning. It was found to be due to inappropriate vasodilation by case control study. The 
objectives of our study were to find out the effect of Cleistanthin C on vascular resistance 
and to see the effects of catecholamines like phenylephrine, adrenaline and noradrenaline 
and in the presence of Cleistanthin C.  
Blood pressure was recorded in rat hind limb preparation using CMC Daq and the 
resistance was computed using a software developed in our department.  
Effect of Cleistanthin C on vascular resistance 
Cleistanthin C 100 µM did not produce any change in the blood pressure. When the 
vascular resistance was calculated it was found that Cleistanthin C 100 µM did not 
produce any change in vascular resistance also.  
P = 0.344 by Wilcoxon signed rank test. 
But Cleistanthin C 500µM increased the vascular resistance significantly. 
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P = 0.043 by Wilcoxon signed rank test. 
In control group 30% ethanol was added instead of Cleistanthin C as Cleistanthin C was 
diluted in 30% ethanol for experiments. Ethanol also did not produce any change in blood 
pressure and vascular resistance. 
P = 0.161 by Wilcoxon signed rank test. 
The change in resistances in the experiment group and control group were compared 
using Mann- Whitney U test. The percentage change in the vascular resistance after 
Cleistanthin C 100µM was found to be not significantly different compared to ethanol 
30% (P = 0.135). But percentage change in vascular resistance after Cleistanthin C 
500µM was significantly different compared to ethanol group (P = 0.001 by Mann- 
Whitney U test). 
Effect of catecholamines in the presence of Cleistanthin C 
Adrenaline 
Adrenaline, 15µM was added in the presence of Cleistanthin C, 100µM. Adrenaline 
increased the blood pressure as well as the resistance.  
P = 0.028 by Wilcoxon signed rank test. 
In control group, Adrenaline was added in the presence of ethanol and here also 
adrenaline increased the vascular resistance. 
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P = 0.028 by Wilcoxon signed rank test. 
The vascular resistance after addition of adrenaline was compared between control and 
experiment group and was found to be insignificant. (P = 0.262 by Mann- Whitney U 
test). 
Noradrenaline 
In the second set of experiments, Noradrenaline, 12µM was added in the presence of 
Cleistanthin C, 100µM. Here also vascular resistance was increased in the presence of 
Noradrenaline. 
P = 0.028 by Wilcoxon signed rank test. 
In control group, noradrenaline was added after ethanol and the vascular resistance was 
found to be increased.  
P = 0.043 by Wilcoxon signed rank test. 
Comparison of vascular resistance after addition of noradrenaline between experiment 
and control group was found to be insignificant by Mann- Whitney U test (P = 0.057). 
Phenylephrine 
In the third set of experiment the catecholamine used was phenylephrine. Similar to first 
two groups in the presence of Cleistanthin C phenylephrine increased the vascular 
resistance.  
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P = 0.028 by Wilcoxon signed rank test. 
In control group also phenylephrine increased vascular resistance. 
P = 0.043 by Wilcoxon signed rank test. 
The change in the vascular resistance after addition of phenylephrine was compared and 
was found to be not significant.  
P = 0.119 by Mann- Whitney U test. 
Effect of catecholamines in the presence Cleistanthin C 500µM 
To reduce the animal usage we did two experiments to confirm that catecholamines are 
increasing vascular resistance in the presence of Cleistanthin C 500µM also.  
The results show that Cleistanthin C, 500µM can increase the vascular resistance but not 
the 100µM. In the presence of Cleistanthin C (100µM as well as 500µM) catecholamines 
can increase the vascular resistance as they are supposed to do.   
84 
 
CONCLUSION 
 
Cleistanthus collinus poisoning is very common in Tamil Nadu. One of the toxic 
components of Cleistanthus collinus is Cleistanthin C. The aim of our study was to assess 
the effect of Cleistanthin C on vascular resistance as hypotension is a common symptom 
in these poisoning patients that can lead to shock and death of the patient.  
The blood pressure was recorded in rat hind limb preparation using a pressure transducer 
connected to CMC Daq. Resistance was calculated from the blood pressure curve and the 
flow curve using curve fitting method by a software developed in our department. 
Cleistanthin C at high dose 500µM increased the vascular resistance compared to the 
control group.  
As catecholamines are used widely for the treatment of hypotension and shock; 
catecholamines like phenylephrine, adrenaline and noradrenaline were added after 
Cleistanthin C. All the catecholamines increased the vascular resistance as it was 
supposed to do and there was no statistically significant difference between the 
Cleistanthin C group and the control group. 
The results show that Cleistanthin C at high dose increases vascular resistance and 
catecholamines can increase resistance in the presence of Cleistanthin C. 
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LIMITATIONS 
 
1. Resistance was computed using two element Windkessel model instead of a three or 
four element Windkessel model for ease. The resistance derived by this method 
underestimated the actual resistance by approximately 9%. This difference may have 
been avoided if higher degree models had been used. 
2. In our lab Cleistanthin C produced hypotension in whole animal experiments. The rat 
hind limb preparation is an open environment. So if Cleistanthin C is producing 
hypotension via Nitric oxide, it may escape from the rat hind limb preparation. 
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